Plain-English translation of NCT07089381 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether resveratrol, a natural substance found in grapes and red wine, can help people with rheumatoid arthritis feel better when combined with their regular arthritis medications. About 118 people will join the study for 3 months: half will take their usual treatment plus a daily resveratrol tablet, and the other half will take their usual treatment alone. Researchers will measure how well the medication reduces inflammation, decreases joint disease activity, and improves quality of life.
Current arthritis treatments help many patients, but some people still experience ongoing inflammation and difficulty with daily activities. This medication is being studied because it may have anti-inflammatory and antioxidant properties that could reduce inflammation and improve how patients feel and function.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either continue your regular arthritis care alone or to add one 1000 mg tablet of resveratrol daily to your regular care. The study lasts 3 months, during which researchers will measure inflammation markers in your blood, assess your joint disease activity, and ask you to complete questionnaires about your quality of life and ability to perform daily activities. You will also be monitored for any side effects from the medication.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt